Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | CA7 | P43166 | 2/20 | 0.61 |
| ▸ | CA9 | Q16790 | 2/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.61 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | SNCA | P37840 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9294233 | 1.00 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9639720 | 0.85 | HSD17B10 (0.52) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9294987 | 0.84 | CA12 (0.64) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9294982 | 0.84 | CA12 (0.64) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5960451 | 0.83 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5960447 | 0.83 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL26744668 | 0.83 | TRPA1 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1647970 | 0.82 | TRPA1 (0.63) | CA12CA1CA2CA7CA9 | |
| SCHEMBL21530613 | 0.82 | TRPA1 (0.63) | CA12CA1CA2CA7CA9 | |
| SCHEMBL30477514 | 0.82 | TRPA1 (0.63) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230355557-A1 | ANTIVIRAL SOX INHIBITORS | GERTRUDE BIOMEDICAL PTY LTD (AU) | 2023-11-09 | — | — | US | disclosed |
| US-20230355557-A1 | ANTIVIRAL SOX INHIBITORS | GERTRUDE BIOMEDICAL PTY LTD (AU) | 2023-11-09 | — | — | US | disclosed |
| US-20230355557-A1 | ANTIVIRAL SOX INHIBITORS | GERTRUDE BIOMEDICAL PTY LTD (AU) | 2023-11-09 | — | — | US | disclosed |
| WO-2022040719-A1 | ANTIVIRAL SOX INHIBITORS | GERTRUDE BIOMEDICAL PTY LTD (AU) | 2022-03-03 | — | — | WO | disclosed |
| US-5371062-A | Herbicides | BAYER AKTIENGESELLSCHAFT (DE) | 1994-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355557-A1 | ANTIVIRAL SOX INHIBITORS | SOX18, IRF3, YBX1 | CA12 3381/4885CA1 3889/4885CA2 3290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.